GlassScriptPhysician profile
Sarah Barlow
NPI 1457360422
$611.52
in general payments reported to CMS, 2019-2025
10 companies · $63.35 in 2025
The $63.35 reported for 2025 was less than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2021: $102 · 2022: $16.16 · 2023: $17.54 · 2024: $172 · 2025: $63.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $171.50 | 2019 | |
| Ethicon US, LLC | $151.11 | 2021-2024 | Echelon; Endopath, Ethicon |
| Novo Nordisk INC | $74.88 | 2019-2024 | |
| Janssen Biotech, INC. | $69.74 | 2019-2022 | |
| Abbvie INC. | $33.83 | 2021 | |
| Genzyme Corporation | $29.57 | 2024 | |
| Mauna Kea Technologies, INC. | $23.85 | 2025 | |
| Intrabio INC | $22.66 | 2025 | Aqneursa |
| Pharming Healthcare, INC. | $17.54 | 2023 | Ruconest |
| Alcresta Therapeutics, INC. | $16.84 | 2025 | Relizorb |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Barlow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.